TY - JOUR
T1 - Heterocycle-fused lupane triterpenoids inhibit Leishmania donovani amastigotes
AU - Haavikko, Raisa
AU - Nasereddin, Abedelmajeed
AU - Sacerdoti-Sierra, Nina
AU - Kopelyanskiy, Dmitry
AU - Alakurtti, Sami
AU - Tikka, Mari
AU - Jaffe, Charles L.
AU - Yli-Kauhaluoma, Jari
PY - 2014/4
Y1 - 2014/4
N2 - The synthesis of heterocyclic betulin derivatives and their activity against Leishmania donovani is reported. Betulonic acid was used as a versatile intermediate. Several different fused heterocycles were introduced at the 2,3-position of the lupane skeleton including isoxazole, pyrazine, pyridine, indole and pyrazole rings. Also the 28-position was modified. Three compounds, 5, 8 and 25, showed low micromolar activity with IC50 values of 13.2, 4.3 and 7.2 μM, respectively. Compound 8 showed the best activity and selectivity, and its activity was tested on infected macrophages using a concentration, 5 μM, where no macrophage toxicity was exhibited. Interestingly, the activity of compound 8 on axenic amastigotes and Leishmania-infected macrophages was similar.
AB - The synthesis of heterocyclic betulin derivatives and their activity against Leishmania donovani is reported. Betulonic acid was used as a versatile intermediate. Several different fused heterocycles were introduced at the 2,3-position of the lupane skeleton including isoxazole, pyrazine, pyridine, indole and pyrazole rings. Also the 28-position was modified. Three compounds, 5, 8 and 25, showed low micromolar activity with IC50 values of 13.2, 4.3 and 7.2 μM, respectively. Compound 8 showed the best activity and selectivity, and its activity was tested on infected macrophages using a concentration, 5 μM, where no macrophage toxicity was exhibited. Interestingly, the activity of compound 8 on axenic amastigotes and Leishmania-infected macrophages was similar.
UR - http://www.scopus.com/inward/record.url?scp=84896906313&partnerID=8YFLogxK
U2 - 10.1039/c3md00282a
DO - 10.1039/c3md00282a
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:84896906313
SN - 2040-2503
VL - 5
SP - 445
EP - 451
JO - MedChemComm
JF - MedChemComm
IS - 4
ER -